Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Filter bei nächster Suche beibehalten
collection:"CTG"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Safety%22&type=Subject&filter%5B%5D=collection%3ACTG
/vufind/Search/Results?lookfor=%22Safety%22&type=Subject&filter%5B%5D=collection%3ACTG
Search /vufind/Search2/Results?lookfor=%22Safety%22&type=Subject&filter%5B%5D=collection%3ACTG
PubPharm (2.144)
1
Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia : Open-label, Single-arm Trial to Evaluate Antitumor Activity, Safety, and Pharmacokinetics of Isatuximab Used in Combination With Chemotherapy in PediatricPatients From 28 Days to Less Than 18 Years of Age With Relapsed/Refractory B or T Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia In First or Second Relapse - ISAKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
2
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
3
MERGE: Maralixibat Extension Safety Study Providing Long-term Treatment to Subjects with Cholestatic Liver Disease. : MRX-800: A Long-Term Safety Study of Maralixibat, an Apical Sodium Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
4
MERGE: Maralixibat Extension Safety Study Providing Long-term Treatment to Subjects with Cholestatic Liver Disease. : MRX-800: A Long-Term Safety Study of Maralixibat, an Apical Sodium Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
5
Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia : Open-label, Single-arm Trial to Evaluate Antitumor Activity, Safety, and Pharmacokinetics of Isatuximab Used in Combination With Chemotherapy in PediatricPatients From 28 Days to Less Than 18 Years of Age With Relapsed/Refractory B or T Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia In First or Second Relapse - ISAKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
6
The effectiveness of online education, feedback and lessons to improve older driver safety. : The relative effectiveness of tailored lessons, workshops and feedback on older drivers’ on-road safety over 12 months.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
7
Isatuximab in Combination with Chemotherapy in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia : Open-label, Single-arm Trial to Evaluate Antitumor Activity, Safety, and Pharmacokinetics of Isatuximab Used in Combination With Chemotherapy in PediatricPatients From 28 Days to Less Than 18 Years of Age With Relapsed/Refractory B or T Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia In First or Second Relapse - ISAKIDS
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
8
High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety : High-dose intravenous silibinin infusions during 10 days as add-on treatment to triple therapy (telaprevir, peginterferon alpha and ribavirin) in cirrhotic GT 1 hepatitis C virus infected patients being null responders to prior dual therapy with peginterferon alpha and ribavirin – a proof-of-concept trial on antiviral efficacy and safety - HISTORY
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
9
MERGE: Maralixibat Extension Safety Study Providing Long-term Treatment to Subjects with Cholestatic Liver Disease. : MRX-800: A Long-Term Safety Study of Maralixibat, an Apical Sodium Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
10
MERGE: Maralixibat Extension Safety Study Providing Long-term Treatment to Subjects with Cholestatic Liver Disease. : MRX-800: A Long-Term Safety Study of Maralixibat, an Apical Sodium Dependent Bile Acid Transporter Inhibitor (ASBTi), in the Treatment of Cholestatic Liver Disease in Subjects Who Previously Participated in a Maralixibat Study.
enthalten in:
WHO International Clinical Trials Registry Platform
| 2023
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[215]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
2.144
Aufsätze
2.144
E-Artikel
2.144
E-Ressourcen
Zeitschriftentitel
1.628
WHO International Clinical Trials Registry Plat...
516
ClinicalTrials.gov
Thema
2.144
610
1.914
Study Type: Interventional
926
Recruitment Status: Not yet recruiting
580
Recruitment Status: Completed
279
Phase: Phase 1
251
Phase: Phase 2
249
Phase: Phase 3
235
Recruitment Status: Recruiting
207
Study Type: Observational
174
Recruitment Status: Authorised-recruitment may ...
144
Phase: Phase 4
51
Recruitment Status: Unknown status
47
Medical Condition: Safety Issues
34
Recruitment Status: Active, not recruiting
32
Recruitment Status: Complete: follow-up complete
29
Phase: Phase 1/Phase 2
24
Medical Condition: This is a study of the long ...
21
Medical Condition: Drug Safety
20
Medical Condition: Open-label, Single-arm Trial...
20
Recruitment Status: Terminated
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1.102
2020-
1.038
2010-2019
4
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.120
Englisch
10
Unbestimmt
6
Spanisch
4
Niederländisch
2
Dänisch
2
Deutsch
Alle anzeigen ...
weniger ...
Haven't found what you're looking for?
Wird geladen...